Computer as psychotherapist?
The Carlat Psychiatry Report, Volume 6, Number 7&8, July 2008
https://www.thecarlatreport.com/newsletter-issue/tcprv6n7-8/
Issue Links: Learning Objectives | Editorial Information
Topics: Psychotherapy
Mark Zimmerman, MD
Cognitive behavior therapy (CBT) is widely acknowledged to be the most well-researched, and possibly the most effective therapy option for a wide variety of disorders. The problem is that it is not widely available, particularly in the treatment of patients with substance abuse disorders.
You can't view details of this content, please login or buy subscription here
Mark Zimmerman, MD
Director of Outpatient Psychiatry, Rhode Island Hospital Associate Professor of Psychiatry and Human Behavior Brown University School of Medicine
Dr. Zimmerman has disclosed that over the past 12 months he has been on the speaker’s bureaus for GlaxoSmithKline (and has spoken about the use of Wellbutrin) and for Wyeth Pharmaceuticals (Effexor XR and Pristiq), and has received between $20,000 and $50,000 for these activities. He has also received research grant support from Sepracor for the study of Lunesta, and has received between $20,000 and $50,000 for this activity. Dr. Carlat has determined that these financial relationships have not commercially biased this presentation.